Search details
1.
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.
Front Oncol
; 9: 759, 2019.
Article
in English
| MEDLINE | ID: mdl-31456944
2.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Clin Cancer Res
; 13(21): 6518-26, 2007 Nov 01.
Article
in English
| MEDLINE | ID: mdl-17975165
3.
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
JCO Precis Oncol
; 22018.
Article
in English
| MEDLINE | ID: mdl-31517176
4.
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Breast
; 16(3): 280-92, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17257844
5.
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.
J Exp Clin Cancer Res
; 36(1): 174, 2017 Dec 04.
Article
in English
| MEDLINE | ID: mdl-29202823
6.
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Acta Biomed
; 87(1): 54-63, 2016 05 06.
Article
in English
| MEDLINE | ID: mdl-27163896
7.
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation.
J Thorac Oncol
; 11(7): 1051-63, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27006151
8.
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Tumori
; 91(6): 505-12, 2005.
Article
in English
| MEDLINE | ID: mdl-16457150
9.
HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer.
Acta Cytol
; 49(1): 27-30, 2005.
Article
in English
| MEDLINE | ID: mdl-15717751
10.
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.
Diagn Cytopathol
; 43(11): 941-6, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26152804
11.
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
PLoS One
; 10(11): e0142891, 2015.
Article
in English
| MEDLINE | ID: mdl-26571236
12.
Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer.
Lung Cancer
; 35(3): 243-7, 2002 Mar.
Article
in English
| MEDLINE | ID: mdl-11844597
13.
Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas.
Diagn Cytopathol
; 28(3): 142-6, 2003 Mar.
Article
in English
| MEDLINE | ID: mdl-12619096
14.
Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report.
Tumori
; 100(1): e20-3, 2014.
Article
in English
| MEDLINE | ID: mdl-24675505
15.
Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.
Diagn Cytopathol
; 41(7): 595-8, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-22833420
16.
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
Lung Cancer
; 80(1): 35-8, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23352033
17.
EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.
Appl Immunohistochem Mol Morphol
; 20(4): 356-62, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22710815
18.
Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
Methods Mol Med
; 75: 405-20, 2003.
Article
in English
| MEDLINE | ID: mdl-12407756
19.
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
J Clin Oncol
; 26(11): 1789-96, 2008 Apr 10.
Article
in English
| MEDLINE | ID: mdl-18347005
20.
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat
; 91(2): 203-5, 2005 May.
Article
in English
| MEDLINE | ID: mdl-15868448